The findings from the NLST have had a significant impact on public health policy by providing evidence to support the implementation of LDCT screening programs. As a result, Medicare and many private insurers now cover LDCT lung cancer screening for eligible high-risk individuals. This has increased access to early detection and potentially improved lung cancer outcomes on a national scale.
